Discovery of Darovasertib (NVP-LXS196), a Pan-PKC Inhibitor for the Treatment of Metastatic Uveal Melanoma
Journal of Medicinal Chemistry · 25.01.2024 · 67 (2) · 1447-1459
DOI: 10.1021/acs.jmedchem.3c02002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 10.01.2024. Verfasst von Michael Visser und 26 weiteren Autor:innen. Beteiligte Einrichtung: Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States. Hauptthemen laut MEDLINE: Melanoma, Uveal Neoplasms. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.
ORCID-Profile: Michael Visser, Julien P N Papillon, Matthew J LaMarche, Rosemary Barrett
Zitieren
APA
Visser, M., Papillon, J. P. N., Luzzio, M., LaMarche, M. J., Fan, J., Michael, W., Wang, D., Zhang, A., Straub, C., Mathieu, S., Kato, M., Palermo, M., Chen, C., Ramsey, T., Joud, C., Barrett, R., Vattay, A., Guo, R., Bric, A., …, & Cooke, V. G. (2024). Discovery of Darovasertib (NVP-LXS196), a Pan-PKC Inhibitor for the Treatment of Metastatic Uveal Melanoma. Journal of Medicinal Chemistry, 67(2), 1447-1459. https://doi.org/10.1021/acs.jmedchem.3c02002
Vancouver
Visser M, Papillon JPN, Luzzio M, LaMarche MJ, Fan J, Michael W, et al. Discovery of Darovasertib (NVP-LXS196), a Pan-PKC Inhibitor for the Treatment of Metastatic Uveal Melanoma. Journal of Medicinal Chemistry. 2024;67(2):1447-1459. doi:10.1021/acs.jmedchem.3c02002
BibTeX
@article{Visser2024,
author = {Visser, Michael and Papillon, Julien P N and Luzzio, Michael and LaMarche, Matthew J and Fan, Jianmei and Michael, Walter and Wang, David and Zhang, Alan and Straub, Christopher and Mathieu, Simon and Kato, Mitsunori and Palermo, Mark and Chen, Christine and Ramsey, Timothy and Joud, Carol and Barrett, Rosemary and Vattay, Anthony and Guo, Ribo and Bric, Anka and Chung, Franklin and Liang, Guiqing and Romanowski, Michael J and Lam, Joni and Thohan, Sanjeev and Atassi, Faraj and Wylie, Andrew and Cooke, Vesselina G},
title = {Discovery of Darovasertib (NVP-LXS196), a Pan-PKC Inhibitor for the Treatment of Metastatic Uveal Melanoma},
journal = {Journal of Medicinal Chemistry},
year = {2024},
volume = {67},
number = {2},
pages = {1447--1459},
doi = {10.1021/acs.jmedchem.3c02002}
}
EUVIMED